HLB Therapeutics Co., Ltd. (115450) Ownership - Who Owns HLB Therapeutics Co., Ltd.?
HLB Therapeutics Co., Ltd. (115450) Ownership Overview
- 2.41% Mutual Funds
- 2.56% ETFs
- 95.03% Public Companies and Individual Investors
The ownership structure of HLB Therapeutics Co., Ltd. (KR:115450) stock is a mix of institutional, retail, and individual investors. Approximately 4.97% of the company’s stock is owned by Institutional Investors, and 95.03% is owned by Public Companies and Individual Investors.
The ownership structure of HLB Therapeutics Co., Ltd. (KR:115450) stock is a mix of institutional, retail, and individual investors. Approximately 4.97% of the company’s stock is owned by Institutional Investors, and 95.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 2,271,746 | Institution | 2.40% | 4,666,166 |
| Vanguard Star Funds | 1,102,527 | Institution | 1.16% | 2,264,590 |
| Vanguard Tax-managed Funds | 717,111 | Institution | 0.76% | 1,472,946 |
| Vanguard International Equity Index Funds | 442,769 | Institution | 0.47% | 909,448 |
| Dimensional | 113,627 | Institution | 0.12% | 233,390 |
| State Street | 38,419 | Institution | 0.04% | 78,913 |
| Dfa Investment Dimensions Group Inc | 21,059 | Institution | 0.02% | 43,255 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 1,102,527 | Institution | 1.16% | 2,264,590 |
| Vanguard Tax-managed Funds | 717,111 | Institution | 0.76% | 1,472,946 |
| Vanguard International Equity Index Funds | 442,769 | Institution | 0.47% | 909,448 |
| Dfa Investment Dimensions Group Inc | 21,059 | Institution | 0.02% | 43,255 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 1,102,527 | Institution | 1.16% | 2,069,805 |
| Vanguard, VEA ETF | 717,111 | Institution | 0.76% | 1,346,252 |
| Vanguard, VSS ETF | 308,144 | Institution | 0.33% | 578,487 |
| Dimensional, DFEM ETF | 74,881 | Institution | 0.08% | 140,020 |
| Dimensional, DFAE ETF | 69,756 | Institution | 0.07% | 130,436 |
| Vanguard, VPL ETF | 62,988 | Institution | 0.07% | 118,249 |
| Vanguard, VT ETF | 45,030 | Institution | 0.05% | 84,536 |
| State Street, GWX ETF | 38,419 | Institution | 0.04% | 71,839 |
| Vanguard, TSE:VIU ETF | 15,882 | Institution | 0.02% | 25,895 |
| Vanguard, VSGX ETF | 13,458 | Institution | 0.01% | 25,778 |
FAQ
What percentage of HLB Therapeutics Co., Ltd. (KR:115450) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.97% of HLB Therapeutics Co., Ltd. (KR:115450) stock is held by institutional investors: 2.41% by mutual funds and 2.56% by ETFs.
What percentage of HLB Therapeutics Co., Ltd. (KR:115450) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.03% of HLB Therapeutics Co., Ltd. (KR:115450) stock is held by public companies and individual investors.
Who owns the most shares of HLB Therapeutics Co., Ltd. (KR:115450)?
Vanguard owns the most shares of HLB Therapeutics Co., Ltd. (KR:115450).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
